Liothyronine I-131

DB12425InvestigationalSmall molecule

Liothyronine I-131 has been used in trials studying the treatment of Tricuspid Atresia and Heart Defects, Congenital.

Chemical structure of Liothyronine I-131
Formula / weight
C15H12I3NO4 · 662.982 g/mol (avg)
Also known as
Liothyronine I 131

Resolves to

Compound
UNII86AZ0G22V2CAS20196-64-9ChEMBLCHEMBL2106622PubChem23724940
Structure
InChIKeyAUYYCJSJGJYCDS-UMVFHIKJSA-NSMILESN[C@@H](CC1=CC([131I])=C(OC2=CC([131I])=C(O)C=C2)C([131I])=C1)C(O)=O

What you can answer from here — as of April 02, 2025

67Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Liothyronine I-131, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In